122 related articles for article (PubMed ID: 15015612)
1. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
Piao BK; Wang YX; Xie GR; Mansmann U; Matthes H; Beuth J; Lin HS
Anticancer Res; 2004; 24(1):303-9. PubMed ID: 15015612
[TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical effects of mistletoe against breast cancer.
Marvibaigi M; Supriyanto E; Amini N; Abdul Majid FA; Jaganathan SK
Biomed Res Int; 2014; 2014():785479. PubMed ID: 25136622
[TBL] [Abstract][Full Text] [Related]
3. Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone - efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment.
Schnell-Inderst P; Steigenberger C; Mertz M; Otto I; Flatscher-Thöni M; Siebert U
Ger Med Sci; 2022; 20():Doc10. PubMed ID: 36160875
[TBL] [Abstract][Full Text] [Related]
4. Small, novel proteins from the mistletoe Phoradendron tomentosum exhibit highly selective cytotoxicity to human breast cancer cells.
Johansson S; Gullbo J; Lindholm P; Ek B; Thunberg E; Samuelsson G; Larsson R; Bohlin L; Claeson P
Cell Mol Life Sci; 2003 Jan; 60(1):165-75. PubMed ID: 12613665
[TBL] [Abstract][Full Text] [Related]
5. Clinical Study of 32 Patients with Advanced Pancreatic Cancer Treated with Traditional Chinese Medicine Combined with Chemotherapy.
Shi L; Geng X; Wang Z; Wang H; Zhang Y
Altern Ther Health Med; 2024 May; ():. PubMed ID: 38743885
[TBL] [Abstract][Full Text] [Related]
6. Automated plan-recognition of chemotherapy protocols.
Bhatia H; Levy M
AMIA Annu Symp Proc; 2011; 2011():108-14. PubMed ID: 22195061
[TBL] [Abstract][Full Text] [Related]
7. Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?
Ziegler R
Evid Based Complement Alternat Med; 2009 Mar; 6(1):19-30. PubMed ID: 18955241
[TBL] [Abstract][Full Text] [Related]
8. Correction: Innovative snail-mucus-extract (SME)-coated nanoparticles exhibit anti-inflammatory and anti-proliferative effects for potential skin cancer prevention and treatment.
Consoli V; Petralia S; Vanella L; Gulisano M; Maugeri L; Satriano C; Montenegro L; Castellano A; Sorrenti V
RSC Adv; 2024 Apr; 14(20):14357. PubMed ID: 38694554
[TBL] [Abstract][Full Text] [Related]
9. Mistletoe therapy in oncology.
Horneber MA; Bueschel G; Huber R; Linde K; Rostock M
Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD003297. PubMed ID: 18425885
[TBL] [Abstract][Full Text] [Related]
10. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
[TBL] [Abstract][Full Text] [Related]
11. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study.
Bar-Sela G; Wollner M; Hammer L; Agbarya A; Dudnik E; Haim N
Eur J Cancer; 2013 Mar; 49(5):1058-64. PubMed ID: 23218588
[TBL] [Abstract][Full Text] [Related]
12. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival.
Tröger W; Galun D; Reif M; Schumann A; Stanković N; Milićević M
Eur J Cancer; 2013 Dec; 49(18):3788-97. PubMed ID: 23890767
[TBL] [Abstract][Full Text] [Related]
13. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study.
Kim KC; Yook JH; Eisenbraun J; Kim BS; Huber R
BMC Complement Altern Med; 2012 Oct; 12():172. PubMed ID: 23033982
[TBL] [Abstract][Full Text] [Related]
14. Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies.
Kienle GS; Kiene H
Integr Cancer Ther; 2010 Jun; 9(2):142-57. PubMed ID: 20483874
[TBL] [Abstract][Full Text] [Related]
15. Safety of intravenously applied mistletoe extract - results from a phase I dose escalation study in patients with advanced cancer.
Huber R; Schlodder D; Effertz C; Rieger S; Tröger W
BMC Complement Altern Med; 2017 Sep; 17(1):465. PubMed ID: 28923036
[TBL] [Abstract][Full Text] [Related]
16. Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study.
Beuth J; Schneider B; Schierholz JM
Anticancer Res; 2008; 28(1B):523-7. PubMed ID: 18383896
[TBL] [Abstract][Full Text] [Related]
17. The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
Semiglasov VF; Stepula VV; Dudov A; Lehmacher W; Mengs U
Anticancer Res; 2004; 24(2C):1293-302. PubMed ID: 15154663
[TBL] [Abstract][Full Text] [Related]
18. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
19. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
